During the past decade, Accellacare - Wilmington conducted 26 clinical trials. In the 10-year time frame, 26 clinical trials started and 8 clinical trials were completed, i.e. on average, 30.8% percent of trials that started reached the finish line to date. In the past 5 years, 25 clinical trials started and 8 clinical trials were completed. i.e. 32% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Accellacare - Wilmington" #1 sponsor was "Pfizer" with 15 trials, followed by "BioNTech SE" with 3 trials sponsored, "Janssen Research & Development, LLC" with 2 trials sponsored, "Janssen Vaccines & Prevention B.V." with 2 trials sponsored and "Evofem Inc." with 2 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Accellacare - Wilmington" #1 collaborator was "Pfizer" with 3 trials as a collaborator and "TIMI Study Group" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Accellacare - Wilmington" are "COVID-19" (8 trials), "SARS-CoV-2 Infection" (4 trials), "Pneumococcal Disease" (3 trials), "Influenza, Human" (2 trials) and "Chlamydia" (1 trials). Many other conditions were trialed in "Accellacare - Wilmington" in a lesser frequency.

Most popular intervention types in "Accellacare - Wilmington" are "Biological" (16 trials), "Drug" (9 trials) and "Other" (6 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (14 trials), "BNT162b2" (3 trials), "PF-07321332" (3 trials), "Ritonavir" (3 trials) and "Saline" (3 trials). Other intervention names were less common.

The vast majority of trials in "Accellacare - Wilmington" are 24 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Accellacare - Wilmington". undefined are not yet recruiting, 7 are recruiting, 6 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 12 completed trials in Accellacare - Wilmington, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Accellacare - Wilmington, 1 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 17 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".